Cytokine-induced sickness behavior was recognized within a few years of the cloning and expression of interferon-, IL-1 and IL-2, which occurred around the time that the Wrst issue of Brain, Behavior, and Immunity was published in 1987. Phase I clinical trials established that injection of recombinant cytokines into cancer patients led to a variety of psychological disturbances. It was subsequently shown that physiological concentrations of proinXammatory cytokines that occur after infection act in the brain to induce common symptoms of sickness, such as loss of appetite, sleepiness, withdrawal from normal social activities, fever, aching joints and fatigue. This syndrome was deWned as sickness behavior and is now recognized to be part of a motivational system that reorganizes the organism's priorities to facilitate recovery from the infection. Cytokines convey to the brain that an infection has occurred in the periphery, and this action of cytokines can occur via the traditional endocrine route via the blood or by direct neural transmission via the aVerent vagus nerve. The Wnding that sickness behavior occurs in all mammals and birds indicates that communication between the immune system and brain has been evolutionarily conserved and forms an important physiological adaptive response that favors survival of the organism during infections. The fact that cytokines act in the brain to induce physiological adaptations that promote survival has led to the hypothesis that inappropriate, prolonged activation of the innate immune system may be involved in a number of pathological disturbances in the brain, ranging from Alzheimer's disease to stroke. Conversely, the newly-deWned role of cytokines in a wide variety of systemic comorbid conditions, ranging from chronic heart failure to obesity, may begin to explain changes in the mental state of these subjects. Indeed, the newest Wndings of cytokine actions in the brain oVer some of the Wrst clues about the pathophysiology of certain mental health disorders, including depression. The time is ripe to begin to move these fundamental discoveries in mice to man and some of the pharmacological tools are already available to antagonize the detrimental actions of cytokines. Published by Elseiver Inc.
Introduction
The Wrst paper on sickness behavior was published in Brain, Behavior, and Immunity (BBI) by Aubert et al. (1995) . Since then, 39 papers on sickness behavior have been published in the journal, which represent 20 percent of the 192 papers published on cytokine-induced sickness behavior that are listed in PubMed. Despite some risk of overlap, it would be fair to add to these statistics the 14 papers on cytokines and depression that were published in BBI in 2002. Although the familiar phrase that "statistics lie and statistician's use statistics" is apropos in the sense that statistics can be used to describe nearly anything one wants them to tell, it is clear from this cursory quantitative review of the literature that BBI has been instrumental in promoting the concept of cytokine-induced sickness behavior. This conclusion becomes even more obvious when these Wgures are compared to the 52 papers on cytokines and the brain that were published by BBI and contrast with the 15,382 papers listed by PubMed in this Weld (as of July 27, 2006) .
